Market data not licensed for redistribution.

Samsung Biologics

207940 · KOSPI · Manufacture of Basic Pharmaceutical Products

– Previous close pending (official data.go.kr feed not active yet) Live price ↗

Source: Financial Services Commission stock price data (data.go.kr), updated once a day.

Daily price, 1 year

Key statistics

Market cap (KRW bn)–

PER–

PBR–

ROE %23.7

Debt ratio % (liabilities / equity)51

Revenue TTM (KRW bn)4,546.8

Op. profit TTM (KRW bn)2,274.1

Dividend yield %–

Basis: market cap at …; equity = total equity (consolidated if available) at 2026.06.30; net income = trailing 12 months to 2026.06.30 (consolidated). PER is not shown when TTM net income is negative.

Upcoming risk events

Next 90 days for this company, plus macro events tagged with this ticker or its sector. Not a recommendation.

2026-11-04	New share sales (rights offerings): final price set (estimate) estimated ↗ 4.90% of shares · size ₩2,665.0bn · 주주배정후 실권주 일반공모	Medium
2026-11-09	New share sales (rights offerings): subscription starts ↗ 4.90% of shares · size ₩2,665.0bn · 주주배정후 실권주 일반공모	Medium
2026-11-17	New share sales (rights offerings): payment date ↗ 4.90% of shares · size ₩2,665.0bn · 주주배정후 실권주 일반공모	Medium

See it in the full calendar →

Annual results (KRW bn)

	2021	2022	2023	2024	2025
Revenue	1,568.0	3,001.3	3,694.6	4,547.3	4,557.0
Operating profit	537.3	983.6	1,113.7	1,320.1	2,069.2
Net income	393.6	798.1	857.7	1,083.3	1,784.4

Quarterly results (KRW bn, 3 months)

	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Revenue	1,298.3	1,289.9	1,660.2	308.6	1,257.1	1,320.9
Operating profit	486.7	475.6	728.8	378.1	580.8	586.4
Net income	375.6	324.4	574.5	510.0	469.2	430.7

Largest shareholder

As of the 2025 annual report: 삼성물산 and related parties hold 74.32% of common shares.

Recent disclosures

Date	Filing
2026-10-30	Governance / misc. (routine) 특수관계인의유상증자참여	DART original
2026-10-30	Governance / misc. (routine) 특수관계인의유상증자참여	DART original
2026-10-30	Insider / major-holder ownership report 임원ㆍ주요주주특정증권등소유상황보고서	DART original
2026-10-30	Insider / major-holder ownership report 임원ㆍ주요주주특정증권등소유상황보고서	DART original
2026-10-28	Insider / major-holder ownership report 임원ㆍ주요주주특정증권등소유상황보고서	DART original
2026-10-26	Insider / major-holder ownership report 임원ㆍ주요주주특정증권등소유상황보고서	DART original
2026-10-26	Insider / major-holder ownership report 임원ㆍ주요주주특정증권등소유상황보고서	DART original
2026-10-26	Insider / major-holder ownership report 임원ㆍ주요주주특정증권등소유상황보고서	DART original
2026-10-26	Insider / major-holder ownership report 임원ㆍ주요주주특정증권등소유상황보고서	DART original
2026-10-26	Insider / major-holder ownership report 임원ㆍ주요주주특정증권등소유상황보고서	DART original
2026-10-26	Insider / major-holder ownership report 임원ㆍ주요주주특정증권등소유상황보고서	DART original
2026-10-26	Insider / major-holder ownership report 임원ㆍ주요주주특정증권등소유상황보고서	DART original

Past material filings and price reaction (market-adjusted)

Date	Filing type	On the news (vs. market)	Next day (vs. market)	20 days (vs. market)
2026-10-02	Single sales/supply contract	-0.5%	-1.9%	–
2026-09-10	Single sales/supply contract	+2.1%	-0.9%	-3.6%
2026-08-31	Acquisition of shares in another company	-0.7%	+0.6%	-8.1%
2026-08-28	Rights offering (paid-in capital increase)	-4.5%	-0.6%	-7.7%
2026-07-23	Preliminary earnings	-0.5%	-3.3%	+14.1%
2026-04-22	Preliminary earnings	+1.4%	-5.2%	-32.5%
2026-03-20	Acquisition of shares in another company	+0.7%	+1.0%	-8.1%
2026-03-20	Rights offering (paid-in capital increase)	+0.7%	+1.0%	-8.1%
2026-03-13	Single sales/supply contract	-0.3%	-2.6%	-8.1%
2026-01-21	Preliminary earnings	-1.5%	-4.4%	-25.6%

For information only, not investment advice. Data may be delayed or inaccurate. Full disclaimer → Data: OpenDART (FSS), stock prices: official previous-day close from the Financial Services Commission (data.go.kr) and FinanceData/marcap history, index data via FinanceDataReader, FX: ECB reference rates, crypto data from Upbit, Bithumb and Binance public APIs.
Market data not licensed for redistribution.
© Crypvu · Crypto market view